XML 45 R33.htm IDEA: XBRL DOCUMENT v3.24.3
Capital Stock, Warrants and Stock Options (Tables)
9 Months Ended
Sep. 30, 2024
Equity [Abstract]  
Schedule of Estimated Using the Binomial Model to Determine the Fair Value of Warrant Liabilities

The fair value of the warrant liabilities related to the various tranches of warrants issued during the period were estimated using the Binomial model to determine the fair value using the following assumptions as at September 30, 2024 and December 31, 2023:

Schedule of Estimated Using the Binomial Model to Determine the Fair Value of Warrant Liabilities 

August 2024 warrants 

September 30,

2024

  

Grant

Date

 
Expected life   1,042 days     1,095 days  
Volatility   100%   105%
Risk free interest rate   2.91%   3.25%
Dividend yield   0%   0%
Share price (C$)  $0.16   $0.16 
Fair value  $92,115   $98,493 
Change in derivative liability  $(6,378)     

 

 

March 2023 warrants 

September 30,

2024

  

December 31,

2023

 
Expected life   543 days     817 days  
Volatility   24%   24%
Risk free interest rate   2.91%   3.88%
Dividend yield   0%   0%
Share price (C$)  $0.16   $0.11 
Fair value  $1,051,876   $281,085 
Change in derivative liability  $770,791      

 

April 2022 special warrants issuance 

September 30,

2024

  

December 31,

2023

 
Expected life   183 days    457 days 
Volatility   60%   110%
Risk free interest rate   2.91%   3.88%
Dividend yield   0%   0%
Share price (C$)  $0.16   $0.11 
Fair value  $1   $546,592 
Change in derivative liability  $(546,591)     

 

April 2022 non-brokered issuance 

September 30,

2024

  

December 31,

2023

 
Expected life   183 days    457 days 
Volatility   60%   110%
Risk free interest rate   2.91%   3.88%
Dividend yield   0%   0%
Share price (C$)  $0.16   $0.11 
Fair value  $1   $21,253 
Change in derivative liability  $(21,252)     

 

June 2022 issuance 

September 30,

2024

  

December 31,

2023

 
Expected life   183 days    457 days 
Volatility   60%   110%
Risk free interest rate   2.91%   3.88%
Dividend yield   0%   0%
Share price (C$)  $0.16   $0.11 
Fair value  $1   $17,589 
Change in derivative liability  $(17,588)     

 

 

February 2021 issuance 

September 30,

2024

  

December 31,

2023

 
Expected life   497 days    771 days 
Volatility   85%   110%
Risk free interest rate   2.91%   3.88%
Dividend yield   0%   0%
Share price (C$)  $0.16   $0.11 
Fair value  $198,474   $367,349 
Change in derivative liability  $(168,875)     

 

June 2019 issuance 

September 30,

2024

  

December 31,

2023

 
Expected life   457 days    731 days 
Volatility   85%   110%
Risk free interest rate   2.91%   3.88%
Dividend yield   0%   0%
Share price (C$)  $0.16   $0.11 
Fair value  $67,374   $226,570 
Change in derivative liability  $(159,196)     

 

August 2019 issuance 

September 30,

2024

  

December 31,

2023

 
Expected life   457 days    731 days 
Volatility   85%   110%
Risk free interest rate   2.91%   3.88%
Dividend yield   0%   0%
Share price (C$)  $0.16   $0.11 
Fair value  $103,545   $348,211 
Change in derivative liability  $(244,666)     
Schedule of Warrant Activity

Outstanding warrants at September 30, 2024 and September 30, 2023 were as follows:

 

Schedule of Warrant Activity 

       Weighted   Weighted 
       average   average 
   Number of   exercise price   grant date 
   warrants   (C$)   value ($) 
             
Balance, December 31, 2022   162,129,064   $0.49   $0.17 
Issued   51,633,727    0.15    0.05 
Expired   (58,284,148)   0.50    0.27 
Exercised   (10,416,667)   0.11    0.12 
Balance, September 30, 2023   145,061,976   $0.37   $0.09 
                
Balance, December 31, 2023   145,061,976   $0.37   $0.09 
                
Issued   1,280,591    0.16    0.08 
Balance, September 30, 2024   146,342,567   $0.37   $0.09 
Schedule of Warrants Outstanding Exercise Price

At September 30, 2024, the following warrants were outstanding:

 

Schedule of Warrants Outstanding Exercise Price 

   Exercise   Number of  

Number of

warrants

 
Expiry date  price (C$)   warrants   exercisable 
             
April 1, 2025   0.37    40,538,969    40,538,969 
December 31, 2025   0.59    32,895,200    32,895,200 
February 9, 2026   0.60    17,112,500    17,112,500 
February 16, 2026   0.60    2,881,580    2,881,580 
March 27, 2026   0.15    51,633,727    51,633,727 
August 8, 2027   0.16    1,280,591    1,280,591 
         146,342,567    146,342,567 
Schedule of Compensation Options

At September 30, 2024, the following broker options were outstanding:

 

Schedule of Compensation Options 

       Weighted 
   Number of   average 
   broker   exercise price 
   options   (C$) 
         
Balance, December 31, 2022   5,470,799   $0.34 
Issued – March 2023 Compensation Options (i)   2,070,258    0.15 
Expired – August 2020 Compensation Options   (3,239,907)   0.35 
Balance, September 30, 2023   4,301,150    0.24 
           
Balance, December 31, 2023   4,301,150    0.24 
Expired – February 2024   (351,000)   0.50 
Expired – April 2024   (1,879,892)   0.30 
Balance, September 30, 2024   2,070,258    0.15 

 

(i) The grant date fair value of the March 2023 Compensation Options was estimated at $111,971 using the Black-Scholes valuation model with the following underlying assumptions:
Schedule of Estimated Using Black-Scholes Valuation Model for Fair Value of Broker Options

Schedule of Estimated Using Black-Scholes Valuation Model for Fair Value of Broker Options

Grant Date 

Risk free

interest rate

   Dividend yield   Volatility   Stock price  Weighted average life
March 2023   3.4%   0%   120%  C$0.11  3 years
Schedule of Broker Exercise Prices

Schedule of Broker Exercise Prices

   Exercise   Number of  

Grant date

Fair value

 
Expiry date  price (C$)   broker options   ($) 
             
March 27, 2026(i)  $0.15    2,070,258   $111,971 
         2,070,258   $111,971 

 

 

i) Exercisable into one March 2023 Unit
Schedule of Stock Options

The following table summarizes the stock option activity during the nine months ended September 30, 2024, and September 30 2023:

 

Schedule of Stock Options 

       Weighted 
       average 
   Number of   exercise price 
   stock options   (C$) 
         
Balance, December 31, 2022   9,320,636   $0.51 
Expired, September 30, 2023   (200,000)  $0.60 
    -    - 
Balance, September 30, 2023   9,120,636   $0.51 
           
Balance, December 31, 2023   8,970,636   $0.52 
Granted (i)   87,493   $0.16 
Balance, September 30, 2024   9,058,129   $0.51 

 

(i) On August 1, 2024, the Company granted 87,493 Stock Options to a certain employee of the Company with all vesting on the first anniversary of the grant date.
Schedule of Actual Stock Options Issued and Outstanding

The following table reflects the actual stock options issued and outstanding as of September 30, 2024:

 

Schedule of Actual Stock Options Issued and Outstanding 

           Number of     
   Remaining   Number of   options     
Exercise  contractual   options   vested   Grant date 
price (C$)  life (years)   outstanding   (exercisable)   fair value ($) 
0.60   0.07    1,575,000    1,575,000    435,069 
0.335   0.08    1,037,977    1,037,977    204,213 
0.55   0.55    5,957,659    5,957,659    1,536,764 
0.15   3.15    400,000    300,000    37,387 
0.16   4.40    87,493    -    7,242 
         9,058,129    8,870,636   $2,220,675